Osiris Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Osiris Therapeutics's estimated annual revenue is currently $300M per year.
- Osiris Therapeutics's estimated revenue per employee is $1,382,488
- Osiris Therapeutics's total funding is $95M.
Employee Data
- Osiris Therapeutics has 217 Employees.
- Osiris Therapeutics grew their employee count by 0% last year.
Osiris Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Scientific Officer | Reveal Email/Phone |
2 | Regional Sales Specialist | Reveal Email/Phone |
3 | National Accounts Manager | Reveal Email/Phone |
4 | Receiving Associate | Reveal Email/Phone |
5 | manufacturing associate | Reveal Email/Phone |
6 | NY Senior Sales Manager | Reveal Email/Phone |
7 | Quality Assurance Associate | Reveal Email/Phone |
8 | Sr. Quality Control Associate | Reveal Email/Phone |
9 | Regional Account Manager | Reveal Email/Phone |
10 | Donor Eligibility Associate | Reveal Email/Phone |
Osiris Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.3M | 2 | 0% | N/A | N/A |
#2 | $3.6M | 46 | -31% | $17.5M | N/A |
#3 | $3.6M | 46 | -34% | $10.5M | N/A |
#4 | $30.2M | 156 | 0% | $69.4M | N/A |
#5 | $11.8M | 76 | -15% | N/A | N/A |
#6 | $1.7M | 11 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $8.8M | 57 | 19% | N/A | N/A |
#9 | $0.2M | 1 | -86% | N/A | N/A |
#10 | $2M | 13 | 18% | N/A | N/A |
What Is Osiris Therapeutics?
Osiris Therapeutics, Inc., is a private development stage biotechnology company that develops adult mesenchymal stem cells (`MSCs") for the regeneration of bone marrow stroma, bone, cartilage and heart muscle tissues that have been damaged by injury, aging or degenerative disease. Osiris is also developing adult MSCs as a delivery platform for gene therapy.
keywords:N/A$95M
Total Funding
217
Number of Employees
$300M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Osiris Therapeutics News
Osiris Therapeutics; NuVasive; Chiesi Pharmaceuticals; Medi-post; JCR Pharmaceutical; MolMed; Pharmicell; Anterogen; Takeda (TiGenix); CBR...
Osiris Therapeutics Medipost Co. Ltd., Anterogen Co. Ltd., Pharmicell Co. Ltd., HolostemTerapieAvanzateSrl, JCR Pharmaceuticals Co.
In April 2019, Osiris Therapeutics, Inc. Announces the Closing of Acquisition by Smith & Nephew plc through the consummation of a merger of...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $64.4M | 217 | 10% | N/A |
#2 | $77.6M | 217 | 4% | N/A |
#3 | $7.5M | 218 | 33% | N/A |
#4 | $78.7M | 218 | 19% | N/A |
#5 | $70.2M | 220 | 10% | N/A |